Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Submitted by
admin
on April 6, 2017 - 9:36am
Source:
Marketwatch
News Tags:
Jazz Pharmaceuticals
Hikma
generics
Xyrem
narcolepsy
Headline:
Jazz Pharmaceuticals stock surges 7% on settlement with Hikma over generic drug
Do Not Allow Advertisers to Use My Personal information
